Dafne Salas-Cuadros, MD retweetledi
Dafne Salas-Cuadros, MD
33 posts

Dafne Salas-Cuadros, MD
@_DafneSC
From 🇵🇪 in 🇺🇸 | Aspiring Internist | MD @UNSA_Oficial | MMSc in Immunology graduate @CayetanoHeredia | Certified @ECFMG_IMG
Delaware Katılım Eylül 2021
191 Takip Edilen82 Takipçiler

Thanks to my dearest friends; this is for you as well.
@eyadomaya, @tonyfeliciano25, @lorena20515, @HersonFS, @OSerrano17, @NavairaShoaib99, @Kasandr40 🙏
English

I am beyond thrilled to share that 🌟 I MATCHED 🌟 in IM at @MyTidalHealth 🎉
A huge thank you to @UNSA_Oficial, @AAPPHealth, Dr Jorge Ballon, Dr Jinsong Zhang, Dr @pongasg, Dr Stephanie Clauss, my amazing husband @MaqueYvan💙and everyone who supported this journey #Match2025


English
Dafne Salas-Cuadros, MD retweetledi

After we reach advanced age, around 80, the propensity to develop cancer is markedly reduced. A discovery reported @Nature today about aged stem cells and iron insufficiency may help explain this advantage
nature.com/articles/d4158… @NatureNV
nature.com/articles/s4158…

English
Dafne Salas-Cuadros, MD retweetledi

Epigenetics-targeted drugs: current paradigms and future challenges
Many drugs are being developed in every field of oncology👇
nature.com/articles/s4139…

English
Dafne Salas-Cuadros, MD retweetledi

Happy Thanksgiving with the most impressive KM curve you’ll see today.
PFS for first line nivo/ipi vs chemo in MSI-H mCRC.
🛻 Truck test: <0.001
nejm.org/doi/full/10.10…

English
Dafne Salas-Cuadros, MD retweetledi

Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
2y PFS➡️72% vs 14%
💥When the right drug is given to the right patient at the right time, the survival curves can be as perfect as the one below👇
nejm.org/doi/full/10.10…

English
Dafne Salas-Cuadros, MD retweetledi

Over the last 50 years, 101 million infants around the world were saved by vaccines. Elevating anti-vaccine conspiracy theories would cost lives. @Morning_Joe

English

Hey @AAPPHealth, let’s keep an eye on things and see if this shifts the direction for the new exam takers.
USMLE@TheUSMLE
The USMLE Management Committee will review the passing standard for Step 1 at its Dec. 2024 meeting. If it's determined that a change is appropriate, the new passing standard will become effective for all examinees who take Step 1 on or after Jan. 1, 2025. bit.ly/3YyoPqi
English
Dafne Salas-Cuadros, MD retweetledi

To understand #autoimmunity, you have to first understand #immunity. @JamesLillard1 walks through the different types of immunity and their role in the immune response. Check out #ImmunologyExplained to learn more: bit.ly/3XZgflj.
English
Dafne Salas-Cuadros, MD retweetledi

📣 NUEVA FORMACIÓN: El próximo lunes 11 noviembre celebramos el Webinar #CáncerdePulmón MAP (Programa de Ayuda MDT) - Fase II, que cuenta con la colaboración de @AstraZenecaES.
💻 Sesión virtual
👉 Acceso a inscripción y programa: saom.es/congresos-curs…
🚀 ¡No te la pierdas!

Español
Dafne Salas-Cuadros, MD retweetledi
Dafne Salas-Cuadros, MD retweetledi

BLU-945, a next-gen EGFR TKI, shows promise against osimertinib-resistant NSCLC, shrinking tumors in preclinical models and in patients from the SYMPHONY trial. This could help fill treatment gaps for EGFR-mutant lung cancer.
Read more:
doi.org/10.1177/175883…

English












